UroGen Pharma Stock Quote URGN - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

13.95

Bid

13.90

Ask

13.98

Volume

21,954

13.84 Day's Range 14.15

8.69 52 Week Range 24.13

Market Cap

477.368M

Previous Close

14.04

Open

14.00

Last Trade

100

13.95

Last Trade Time

10:41:43

Financial Volume

$ 307,507

VWAP

14.0069

Average Volume (3m)

360,581

Shares Outstanding

34,122,087

Dividend Yield

PE Ratio

-4.67

Earnings Per Share (EPS)

-3

Revenue

82.71M

Net Profit

-102.24M

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.urogen.com

Headquarters

Ra'anana, Center, Isr

Founded

1970

UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $14.04. Over the last year, UroGen Pharma shares have traded in a share price range of $ 8.69 to $ 24.13.

UroGen Pharma currently has 34,122,087 shares outstanding. The market capitalization of UroGen Pharma is $477.37 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.67.

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

Subgroup analysis of the UGN-102 ATLAS Trial in patients with new versus recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) Three independent long-term...

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen plans to initiate a Phase 3 study to explore the safety and efficacy of UGN-103 in 2024 Anticipated advantages include a new 80 mg mitomycin dosage strength that may considerably shorten...

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a...

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

Initiated submission of a rolling NDA to the FDA for UGN-102; 12-month duration of response data from ENVISION expected to support completion of NDA submission Announced next-generation novel...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.45	-3.125	14.4	14.85	13.69	166642	14.15622163	CS
4	-0.33	-2.31092436975	14.28	15.5	12.37	297732	14.24964298	CS
12	-1.95	-12.2641509434	15.9	19.87	12.37	360581	16.18783202	CS
26	2.77	24.7763864043	11.18	19.87	10.63	316502	15.18187679	CS
52	2.36	20.3623813632	11.59	24.13	8.69	379963	16.15216156	CS
156	-6.05	-30.25	20	24.13	4.85	206179	14.03593708	CS
260	-22.78	-62.0201470188	36.73	39.97	4.85	199580	18.53189298	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AKLIAkili Inc	$ 0.381 (62.20%)	41.82M
CYCCCyclacel Pharmaceuticals Inc	$ 2.17 (59.56%)	15.47M
AGBAAGBA Group Holding Ltd	$ 3.62 (54.04%)	64.15M
GMMGlobal Mofy Metaverse Ltd	$ 1.39 (49.41%)	50.82M
WGSGeneDx Holdings Corporation	$ 16.109 (46.45%)	1.79M
LICNLichen China Limited	$ 1.4802 (-27.08%)	814.68k
CSLRComplete Solaria Inc	$ 0.58 (-20.57%)	1.65M
NRXPNRX Pharmaceuticals Inc	$ 2.82 (-20.56%)	577.01k
CETXCemtrex Inc	$ 1.42 (-20.22%)	84.2k
LUCYInnovative Eyewear Inc	$ 0.1951 (-19.01%)	145.68k
EGOXNext e GO NV	$ 0.0343 (24.28%)	70.45M
AGBAAGBA Group Holding Ltd	$ 3.62 (54.04%)	64.15M
GWAVGreenwave Technology Solutions Inc	$ 0.0697 (7.23%)	53.96M
GMMGlobal Mofy Metaverse Ltd	$ 1.39 (49.41%)	50.82M
JAGXJaguar Health Inc	$ 0.2435 (17.07%)	44.7M